Literature DB >> 27089920

Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity.

Yuanzhao Zhu1, Junjun Zheng1, Ling Zhang1, Zhenguo Zeng2, Min Zhu1, Xiaobin Li1, Xiaoliang Lou3, Hui Wan1, Daojun Hong4.   

Abstract

BACKGROUND: Reversible splenial lesion syndrome (RESLES) is a disorder radiologically characterized by reversible lesion in the splenium of the corpus callosum (SCC). Most of patients with RESLES associated with encephalitis/encephalopathy were identified in Japanese population, but almost no Chinese patients were diagnosed as RESLES associated with encephalitis/encephalopathy.
METHODS: Possible patients with reversible isolated SCC lesions were retrieved from January 2012 to July 2015 using keyword "restricted diffusion and isolated SCC lesion" in MRI report system from a large academic center. The clinical, laboratory and radiological data were summarized.
RESULTS: A total of 15 encephalitis/encephalopathy patients (9 males and 6 females) were identified with a reversible isolated SCC lesion. Except for 13 patients with fever symptom, 8 patients also had cold symptoms before the onset of neurological symptoms. The neurological symptoms included headache, vertigo, seizure, disturbance of consciousness, and delirious behavior. Thirteen patients completely recovered within 1 month, but 2 patients who were subjected to mechanical ventilation had persistent neurological deficits. The initial MRI features showed isolated ovoid or extending SCC lesions with homogeneous hyperintense on diffusion weighted imaging (DWI) and decreased apparent diffusion coefficient (ADC) values. The follow-up MRI revealed that isolated SCC lesions with diffuse restriction disappeared at 10 to 32 days after the initial MRI study. Fractional anisotropy map revealed the decreased value of SCC lesion in a severe case with poor prognosis.
CONCLUSIONS: RESLES associated with encephalitis/encephalopathy is a reversible syndrome with an excellent prognosis in most patients, while a few patients required ventilator supporting at the early stage might have severe neurological sequelae. Reversible signal changes on DWI and ADC are identified in all patients, but fractional anisotropy values can be decreased in severe patient with neurological sequelae.

Entities:  

Keywords:  Corpus callosum; Encephalitis; Encephalopathy; Poor outcome; Reversible splenial lesion syndrome

Mesh:

Year:  2016        PMID: 27089920      PMCID: PMC4835842          DOI: 10.1186/s12883-016-0572-9

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


Background

Reversible splenial lesion syndrome (RESLES) is characterized by reversible lesion in the central portion of the splenium of corpus callosum (SCC) [1, 2]. RESLES is most often identified in patients with seizures and/or antiepileptic drugs withdrawal [3, 4]. However, it is also frequently observed in encephalitis/encephalopathy caused by various pathogens such as influenza virus, rotavirus, measles, herpesvirus 6, adenovirus, mumps, Epstein-Barr virus, Escherischia coli, and others [5-8]. The neurological symptoms of RESLES associated with encephalitis/encephalopathy can presented with delirious behavior, short disturbance of consciousness, and seizures, but usually had complete recovery without neurological sequelae after a short disease course [9-11]. Therefore at sometimes, RESLES associated with encephalitis/encephalopathy was interchangeably termed as clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) [12, 13]. Most of patients with RESLES associated with encephalitis/encephalopathy were reported in Japanese population [14, 15]. However, there were few published reports of Chinese patients diagnosed as RESLES associated with encephalitis/encephalopathy. In this study, we described the clinical data and outcomes in 15 Chinese patients with RESLES associated with encephalitis/encephalopathy identified retrospectively in order to evaluate the clinical heterogeneity of RESLES associated with encephalitis/encephalopathy.

Methods

We performed a retrospective observational study in an academic hospital. Patients with isolated lesion in the splenium of corpus callosum visited in the first affiliated hospital of Nanchang University between January 2012 and July 2015 were screened for the study. We identified all patients by searching our MRI report system using keyword “restricted diffusion and isolated SCC lesion”. Exclusion criteria include epilepsy-related RESLES, RESLES with additional lesions in white matter, and cases without follow-up MRI. We reviewed and analyzed MRI scans and clinical charts of these patients, including information about symptoms, treatments, prognosis, electroencephalogram (EEG), and results of cerebrospinal fluid (CSF) analysis. The clinical data and radiological examinations were independently evaluated by at least two neurologists firstly. A reversible isolated SCC lesion is defined as a lesion involving the central portion of SCC without any other lesions on the first MRI, which disappears on the follow-up scanning. According to the literatures and clinician consensus, the diagnosis of encephalitis had been defined as acute onset of brain dysfunction such as acute fever, headache, seizures, delirious behavior, and disorders of consciousness with inflammatory changes such as pleocytosis of CSF [2, 16]. When patients presented with prodromal febrile illness, but without evidence of inflammatory change in central nervous system, we used the term encephalopathy [2, 16]. Fever is defined as mouth temperature more than 38 °C within the 72 h before or after presentation. The clinical procedure of etiology investigating for encephalitis includes blood, CSF, and urine cultures; CSF gram stain, India Ink stain, and modified acid-fast stain; CSF polymerase chain reaction (PCR) for herpes simplex virus 1 or 2, Epstein-Barr virus, and influenza A or B; PCR for influenza A or B in nasopharyngeal swabs; herpes simplex virus 1 (HSV1), HSV2, HSV6, cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus serum IgM, and 14 d later for paired IgG antibody testing; routine human immuno-deficiency virus, treponema pallidum agglutination test, and venereal disease research laboratory test. This study was approved by the ethics committee of the First Affiliated Hospital of Nanchang University. The written consent forms for clinical descriptions and radiological images were signed by the patients or their guardians. Herein, two cases with poor outcomes were singled out and described in detail as follows, and other patients’ descriptions were deposited in an Additional file 1.

Case 2

A 23-year-old man with the complaints of fever for 6 days, disturbance of consciousness for 4 h was admitted to the hospital on March 14, 2012. The patient initially presented with cold symptoms including fever, nasal congestion, and pharyngalgia 6 days ago. At the day of admission, he had temperature up to 39 °C, severe headache, and vomiting. He suddenly lost consciousness and experienced a seizure at that night. The symptom of seizure completely stopped after 2–3 min, but coma was persistent. Physical examination on admission revealed comatose state (Glasgow Coma Scale, GCS: 7), cyanosis, stiff neck, and no voluntary movements. The emergent therapy included mechanical ventilation, antiviral (acyclovir), and antibiotics (cefoperazone). At 1 day after admission, he can detach from the ventilator, but still was in comatose state. Cerebral MRI revealed an isolated lesion in the splenium of corpus callosum with slight hyperintense on T2 weighted images (T2WI), slight hypointense on T1 weighted images (T1WI), no enhancement on contrast images, obvious hyperintense on diffusion weighted imaging (DWI) (Fig. 1a), and decreased apparent diffusion coefficient (ADC) values (Fig. 1b). Fractional anisotropy map revealed mildly decreased value of SCC lesion (Fig. 1c), but with normally projecting direction of white matter fibers (Fig. 1f). At 4 days after admission, the patient experienced several seizures again, and became deep comatose (GCS: 5). The patient was administrated with carbamazepine (400 mg/d), methylprednisolone (1000 mg/d), and intravenous immunoglobulin (IVIG) (2 g/kg). The symptoms of seizure gradually disappeared, and the temperature returned to normal limits, while disturbance of consciousness was persistent. Laboratory examination revealed serum chemistry, blood routine, thyroid function, serum ammonia, tumor biomarkers, extractable nuclei antigen (ENA) polypeptide spectrum, and anti-neutrophil cytoplasmic antibody (ANCA) were normal. A lumbar puncture revealed a mild lymphocytic pleocytosis (20 cells/μL) with normal protein and glucose contents. Oligoclonal bands were negative in serum and CSF. The quantity of myelin basic protein (MBP) was 3.8ug/L (normal <4ug/L) in CSF. Intrathecal IgG synthesis rate was 0.55 mg/24 h (normal <0.7 mg/24 h). The etiological procedure found a positive PCR for influenza A in nasopharyngeal swabs, while other extensive microbiological workups were negative. At 17 days after admission, second MRI showed the abnormalities of SCC nearly disappeared on DWI (Fig. 1d) and ADC (Fig. 1e). Spinal cord MRI was normal. At 45 days, he was transferred back to local hospital for nursing care. After 1 year follow-up, the patient was in vegetative state, nasogastric tube feeding, and bedridden.
Fig. 1

The cerebral MRI features of case 2. MRI revealed an isolated SCC lesion with obvious hyperintense on DWI (a, arrow), decreased ADC values (b), decreased fractional anisotropy value (c), and normally projecting direction of white matter fibers (f). At 16 days after initial MRI, second MRI showed the abnormalities of SCC nearly disappeared on DWI (d) and ADC (e)

The cerebral MRI features of case 2. MRI revealed an isolated SCC lesion with obvious hyperintense on DWI (a, arrow), decreased ADC values (b), decreased fractional anisotropy value (c), and normally projecting direction of white matter fibers (f). At 16 days after initial MRI, second MRI showed the abnormalities of SCC nearly disappeared on DWI (d) and ADC (e)

Case 7

A 16-year-old boy with the complaints of fever and headache for 5 days, delirious behaviors for 3 days, and consciousness disturbance for 1 day was admitted to the hospital on February 12, 2014. The boy initially had fever, cough, and headache. After 3 days, the patient presented with severe headache, vomiting, and irritability, so antiviral drug (acyclovir) was administrated. After 4 days, he had consciousness disturbance, but no seizures were observed in the disease course. Physical examination on admission revealed comatose state (GCS: 8), slight limb movements responsive to pain stimulus, and negativity of bilateral pathological reflex. On admission, cerebral MRI showed an isolated lesion in the central SCC with slight hyperintense on T2WI (Fig. 2a), slight hypointense on T1WI (Fig. 2b), hyperintense on DWI (Fig. 2c), and apparent decreased ADC values (Fig. 2d). A lumbar puncture revealed a mild elevation of cell counting (15 cells/uL) with normal protein and glucose content. Oligoclonal bands were negative in serum and CSF. The quantity of MBP was 3.3ug/L in CSF. Intrathecal IgG synthesis rate was 0.61 mg/24 h. Laboratory examination revealed serum chemistry, thyroid function, serum ammonia, tumor biomarkers, ENA polypeptide spectrum, and ANCA were normal. At 1 day after admission, patients experienced more severe disturbance of consciousness, low blood pressure (70/50 mmHg), and breathing difficulty with hypoxemia and acidosis, so mechanical ventilation was administrated immediately. Meanwhile, the patient was administrated with methylprednisolone (1000 mg/d), IVIG (2 g/kg), antiviral (acyclovir), and antibiotics (vancomycin). At 10 days after admission, the patient had stable vital signs, while he was still in comatose state. At 32 days after admission, second MRI showed abnormal signals of the SCC completely disappearing on T2WI (Fig. 2e), T1WI (Fig. 2f), DWI (Fig. 2g) and ADC (Fig. 2h). After 7 months follow-up, the patient was in a condition of agrypnocoma, nasogastric tube feeding, and bedridden.
Fig. 2

The cerebral MRI features of case 7. MRI showed an isolated SCC lesion with slight hyperintense on T2WI (a), slight hypointense on T1WI (b), hyperintense on DWI (c, arrow), and obvious decreased ADC values (d). At 32 days after first MRI, second MRI showed abnormal signals of the SCC completely disappearing on T2WI (e), T1WI (f), DWI (g) and ADC (h)

The cerebral MRI features of case 7. MRI showed an isolated SCC lesion with slight hyperintense on T2WI (a), slight hypointense on T1WI (b), hyperintense on DWI (c, arrow), and obvious decreased ADC values (d). At 32 days after first MRI, second MRI showed abnormal signals of the SCC completely disappearing on T2WI (e), T1WI (f), DWI (g) and ADC (h)

Result

Clinical features Of the 23 patients with restricted diffusion on isolated lesion in SCC, 15 patients met the criteria for RESLES associated with encephalitis/encephalopathy and 8 patients were excluded from the study due to the following reasons: 6 had no follow-up MRI study; 1 had lesions in both SCC and bilateral white matters; 1 was associated with possible epilepsy-related RESLES due to withdrawal of antiepileptic agents. The clinical data and radiological images of 15 patients were reviewed by the co-authors together. The clinical findings of 15 patients were summarized in Table 1.
Table 1

Clinical data of patients with RESLES associated with encephalitis/encephalopathy

patient no.age/sexinitial symptomCNS manifestation (onset day)CNS diagnosisEEGCSFpathogenstherapyprognosis (day)
115/Mfeverheadache (2d)encephalopathyslow BAnormalnegativeNoneCR (14d)
223/Mfever, nasal congestion, pharyngalgiaheadache, seizure, disturbance of consciousness, meningeal irritation sign (6d)meningoencephalitisNECC: 20influenza AMPSL, IVIG, ACV, MV, CBZ, antibiotics,vegetative state
327/Ffever, coughheadache, ataxia, slurred language (2d)encephalopathyNEnormalnegativeDex, ACVCR (9d)
438/Mfever, nasal congestion, coughheadache, vertigo (1d)encephalopathyNEnormalherpesvirus-6ACVCR (11d)
526/Mfever, myalgiasheadache, disturbance of consciousness (2d)encephalitisslow BACC:110negativeACV, Dex, antibioticsCR (10d)
631/Mfever, pharyngalgiavertigo (3d)encephalopathyslow BAnormalnegativeACV, antibioticsCR (20d)
716/Mfever, coughheadache, delirious behavior, disturbance of consciousness (2d)encephalitisNECC: 15negativeMPSL, IVIG, ACV, MV,agrypnocoma
837/Ffever, myalgiasheadache, tremor (1d)encephalopathynormalnormalnegativeNoneCR (25d)
925/Ffever, cough, pharyngalgiaheadache, vertigo (3d)encephalopathyNEnormalinfluenza BACVCR(7d)
1030/Mfeverlimb numbness, slurred language (2d)encephalopathynormalnormalnegativeNoneCR(12d)
1130/Ffever, nasal congestionheadache, delirious behavior (5d)encephalitisnormalnormalEB virusACV, DexCR (7d)
1213/Mfeverheadache, disturbance of consciousness, seizure, meningeal irritation sign (1d)meningoencephalolitisslow BACC: 73negativeACV, PB, IVIG, antibioticsCR (6d)
1333/FnonevertigoencephalopathynormalnormalnegativeNoneCR (14d)
1425/Fcough, pharyngalgiaheadache (3d)encephalopathyNENEnegativeACVCR (10d)
1515/Mfeverheadache (1d)encephalitisnormalCC: 19negativeACV, DexCR (15d)

CNS central nervous system, EEG electroencephalogram, CSF cerebrospinal fluid, BA basic activity, CR complete recovery, NE not examined, CC cell counting (cells/uL), MPSL methylprednisolone, IVIG intravenous immunoglobulin, ACV acyclovir, MV mechanical ventilation, CBZ carbamazepine, SL slurred language, Dex dexamethasone, PB phenobarbital

Clinical data of patients with RESLES associated with encephalitis/encephalopathy CNS central nervous system, EEG electroencephalogram, CSF cerebrospinal fluid, BA basic activity, CR complete recovery, NE not examined, CC cell counting (cells/uL), MPSL methylprednisolone, IVIG intravenous immunoglobulin, ACV acyclovir, MV mechanical ventilation, CBZ carbamazepine, SL slurred language, Dex dexamethasone, PB phenobarbital These patients included 9 males and 6 females, and their age at diagnostic time varied from 13 to 32 years (average 25.6 ± 7.98). Fever preceded neurological symptoms in 13 patients. Eight patients initially had other cold symptoms before the onset of neurological symptoms. The cold symptoms included cough (5/8), pharyngalgia (4/8), nasal congestion (3/8), and myalgias (2/8). Viral pathogens were identified in 4 of 15 patients, including influenza A or B (positive PCR in nasopharyngeal swab), herpesvirus-6 (increased IgM antibody), and Epstein-Barr virus (positive PCR in CSF). The onset of neurological symptoms ranged from day 1 to 6 of the febrile illness. The most common neurological symptom is headache (12/15), followed by disturbance of consciousness (4/15), vertigo (4/15), seizure (2/15), delirious behavior (2/15), slurred language (2/15), ataxia (1/15), tremor (1/15), and limb numbness (1/15). Two patients were treated with mechanical ventilation. Two patients had received antiepileptic drugs (phenobarbital for case 2 and carbamazepine for case 12) after the time of MRI study. Analysis of CSF revealed pleocytosis in 5 of 14 examined patients but normal glucose and protein levels. EEG showed slow basic activity characteristic of encephalitis/encephalopathy in 4 of 9 examined patients. The therapeutic regimens were variable (e.g. acyclovir for 11 patients, corticosteroids for 6 patients, and IVIG administration for 3 patients), even 4 patients were not administrated purposeful treatments. Thirteen patients clinically recovered completely within 1 month (9 patients within 2 weeks after the onset of neurological symptoms) without any neurological sequelae, but 2 patients who were required mechanical ventilation had severe neurological sequelae. MRI characteristics In all of patients, the initial MRI study was performed within 1 week of the onset of prodromal febrile illness (Table 2). On axial images, the lesion was extended irregularly into the lateral portion of SCC in 2 patients (Fig. 1) and ovoid in the center of the SCC in the other patients (case 1, 3, 4, 5, and 7–15) (Fig. 2). There was no obvious correlation between the shape of SCC lesion and the scan date, neurological symptoms (presence or absence of seizures, date of complete recovery, with or without sequelea), or laboratory findings. The initial MRI features showed homogeneously restricted diffusion with hyperintense on DWI and decreased ADC values in SCC lesions. The lesions of SCC were homogeneously slight hyperintense on T2WI, while the lesions can be isointense to slight hypointense on T1WI. There was no enhancement of the SCC lesion after gadolinium administration in any of the 7 patients who received enhanced MRI. The SCC abnormalities of all 15 patients disappeared at follow-up MRI studies performed 10 to 32 days after the first MRI study. In at least 4 patients (case 1, 2, 7, 10), the SCC lesions disappeared before clinical symptoms reached stability or complete recovery.
Table 2

MRI characteristics of RESLES associated with encephalitis/encephalopathy

patient no.initial MRIfollow-up MRI
scan date1 lesionshapeT2WIT1WIGdDWIADCDTIscan date2 scan date2
1day 5SCCovoidHsLNEHLNEday 12none
2day 7SCCextendedsHsLnoneHLLday 16none
3day 4SCCovoidHLNEHLNEday 10none
4day 5SCCovoidsHINEHLNEday 12none
5day 3SCCovoidHsLnoneHLNEday 11none
6day 4SCCovoidsHINEHLNEday 28none
7day 5SCCovoidsHsLNEHLNEday 32none
8day 2SCCovoidsHINEHLNEday 27none
9day 3SCCovoidHLnoneHLNEday 14none
10day 3SCCextendedsHsLNEHLNEday 10none
11day 5SCCovoidsHInoneHLNEday 25none
12day 6SCCovoidsHsLnoneHLNEday 15none
13day 1SCCovoidsHINEHLNEday 17none
14day 4SCCovoidsHsLnoneHLNEday 14none
15day 3SCCovoidHLnoneHLNEday 16none

scan date from the initial symptoms, scan date from the initial MRI. T2W T2-weighted image, T1WI T1-weighted image, Gd gadolinium enhancement, DWI diffusion weighted imaging, ADC apparent diffusion coefficient, DTI diffusion tensor imaging, SCC splenium of the corpus callosum, H high intensity, L low intensity, I isointensity, sH slight high intensity, sL slight low intensity, NE not examined

MRI characteristics of RESLES associated with encephalitis/encephalopathy scan date from the initial symptoms, scan date from the initial MRI. T2W T2-weighted image, T1WI T1-weighted image, Gd gadolinium enhancement, DWI diffusion weighted imaging, ADC apparent diffusion coefficient, DTI diffusion tensor imaging, SCC splenium of the corpus callosum, H high intensity, L low intensity, I isointensity, sH slight high intensity, sL slight low intensity, NE not examined

Discussion

In this study, we described the clinical characteristics and outcomes in 15 patients with RESLES associated with encephalitis/encephalopathy in mainland China. These patients initially presented with febrile illness, and then had CNS manifestations after several days. Due to the limits of pathogens and CSF examinations, 6 patients can be considered as encephalitis, while 9 other patients can be only diagnosed as infection-associated encephalopathy [2, 14]. However, all patients had a complete radiological regression of the isolated SCC lesion within several weeks. Almost all patients with RESLES could be complete recovery without neurological sequelae after the acute disease course [1, 2]. Therefore, RESLES associated with encephalitis/encephalopathy was also known as a type of clinically mild encephalitis/encephalopathy [2, 14]. However, we found two patients (case 2 and 7), who required ventilator supporting in the acute period of disease course, had persistent comatose state and poor prognosis, even though the abnormal lesions disappeared within 1 month. Through detailed clinical investigations, the typical evidences of acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS), autoimmune encephalitis, vasculitis of central nervous system, and various metabolic or toxic encephalopathies were not found in the two patients. Although some rare underlying disorders can not be completely excluded, the clinical pictures of the two patients conformed to the diagnosis of RESLES associated with encephalitis/encephalopathy. Therefore, RESLES associated with encephalitis/encephalopathy should not be simply considered as a mild clinic-radiological disorder with an excellent prognosis, particularly in patients required ventilator supporting in acute stage of disease course. Due to the insufficient number of patients, there had been no evidence-based therapeutic regimen for RESLES associated with encephalitis/encephalopathy. According to the descriptions of literatures, the commonest prescriptions included acyclovir, antibiotics, anti-epileptic drugs, corticosteroids, and IVIG [2, 17]. We also found that the treatment can change from one case to other case in our observational patients; even 4 cases with good prognosis had not been administrated any purposeful treatments. The pathogenesis of the selective splenial lesion is not fully understood in RESLES associated with encephalitis/encephalopathy. Multiple etiologies are considered involvements into the splenial lesion [2, 18, 19]. Therefore, as a distinct radiological spectrum disorder, cerebral MRI still is the first choice to identify lesions of the SCC, particularly to detect early changes, and helps interpret the nature of the lesion [1]. The SCC lesions consistently showed a homogeneous and reversible pattern on DWI, differentiating these lesions from persistent ischemia, where ADC reduction with subsequent reversal is uncommon. Our cases showed reversible DWI and ADC reduction supporting that cytotoxic edema of the SCC is an important mechanism in this condition. Interestedly, we found the SCC lesion presented with decreased fractional anisotropy values in the initial MRI scanning, which was different from the findings described by other cases [20, 21]. The decreased fractional anisotropy values in areas of diffusion restriction may indicate the disarrangement of water molecule motivation along the axonal fibers, which also may indicate the destruction of bridge architecture associated with neurological deficits in the patient. However, the clinical significance between fractional anisotropy value and prognosis should be further investigated in more cases. In addition, some cases with slightly tinny hyperintense on T2 and DWI had severe clinical course and poor outcomes, but other cases with obvious hyperintense on T2 and DWI presented with slight clinical course. The phenomenon might indicate that the intensity and formation of SCC lesion were not closely associated with the clinical features. Since a few patients with ADEM can present with isolated SCC lesion in early stage of disease course [22], ADEM should be a differential diagnosis of RESLES associated with encephalitis/encephalopathy. ADEM is an immune inflammatory disorder, which is clinically characterized as seizures, focal neurological signs, disturbance of consciousness, and recovery after immunomodulatory therapy. MRI in ADEM usually shows multiple foci of T1 and T2 prolongation with enhancement in bilateral or asymmetric subcortical white matters [21]. Therefore, we excluded a case with lesions both SCC and bilateral white matters in order to obtain a more strict clinical diagnosis, although some patients with RESLES associated with encephalitis/encephalopathy were well described with additional white matter lesions [23]. The lesions of ADEM usually evolve over weeks to months and disappear only after several months [21]. However, our patients developed neurological symptoms quickly after the onset of febrile illness. The SCC lesions in these patients had no contrast enhancement, and most of them disappeared completely within month. Therefore, the SCC lesions in our patients are clinically and radiologically different from those of ADEM. Autoimmune encephalitis such as anti-N-methyl-D-aspartate (NMDA) receptor encephalitis also should be differentiated [24]. Corpus callosum can be affected in very few patients with anti-NMDA receptor encephalitis, while the lesions were not quickly reversible diffusion restriction with reduced apparent diffusion coefficient in patients who usually were young female with ovarian teratoma [25]. The major limitations of our work were its retrospective nature and relatively small sample size. A larger prospective study with long-term follow-up would be necessary to corroborate our findings.

Conclusion

RESLES associated with encephalitis/encephalopathy is a distinct disorder, which usually affects children or young adults with febrile illness. Although RESLES associated with encephalitis/encephalopathy is a reversible syndrome with an excellent prognosis in most patients, a few patients required ventilator supporting at the early stage might have severe neurological sequelae. Reversible signal changes on DWI and ADC are identified in all of patients, but fractional anisotropy values can be decreased in severe patient with neurological sequelae.

Ethics and consent to participate

This study was approved by the ethics committee of the First Affiliated Hospital of Nanchang University.

Consent to publish

Written consent for publication had obtained from patients or their parents.

Availability of data and materials

The detailed descriptions about those patients can be available in a Additional file 1.
  25 in total

1.  Kawasaki disease-associated MERS: pathological insights from SPECT findings.

Authors:  Tatsuharu Sato; Yoko Ushiroda; Toshifumi Oyama; Akiko Nakatomi; Hideki Motomura; Hiroyuki Moriuchi
Journal:  Brain Dev       Date:  2011-10-22       Impact factor: 1.961

2.  Transient isolated lesion of the splenium associated with clinically mild influenza encephalitis.

Authors:  Srinivas Ganapathy; Elizabeth H Ey; Barbara J Wolfson; Nadir Khan
Journal:  Pediatr Radiol       Date:  2008-07-31

3.  Mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in a patient presenting with papilledema.

Authors:  Eylem Degirmenci; Taner Degirmenci; Ebru Nevin Cetin; Yılmaz Kıroğlu
Journal:  Acta Neurol Belg       Date:  2014-06-04       Impact factor: 2.396

4.  Oxidative stress in patients with clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS).

Authors:  Rie Miyata; Naoyuki Tanuma; Masaharu Hayashi; Takuji Imamura; Jun-ichi Takanashi; Rieko Nagata; Akihisa Okumura; Hirohumi Kashii; Sunao Tomita; Satoko Kumada; Masaya Kubota
Journal:  Brain Dev       Date:  2011-05-14       Impact factor: 1.961

5.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes.

Authors:  Ai Hoshino; Makiko Saitoh; Akira Oka; Akihisa Okumura; Masaya Kubota; Yoshiaki Saito; Jun-Ichi Takanashi; Shinichi Hirose; Takanori Yamagata; Hideo Yamanouchi; Masashi Mizuguchi
Journal:  Brain Dev       Date:  2011-09-15       Impact factor: 1.961

6.  Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis.

Authors:  T Polster; M Hoppe; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

7.  Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis.

Authors:  Amy Ka; Philip Britton; Christopher Troedson; Richard Webster; Peter Procopis; Joanne Ging; Yew Wee Chua; Adam Buckmaster; Nicholas Wood; Cheryl Jones; Russell C Dale
Journal:  Eur J Paediatr Neurol       Date:  2015-02-13       Impact factor: 3.140

8.  A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible: A case report.

Authors:  Yuji Hashimoto; Jun-ichi Takanashi; Keiko Kaiho; Katsunori Fujii; Toshiyuki Okubo; Setsuo Ota; Yoichi Kohno
Journal:  Brain Dev       Date:  2008-11-28       Impact factor: 1.961

9.  A 4-year-old girl with clinically mild encephalopathy with a reversible splenial lesion associated with rotavirus infection.

Authors:  Tatsuo Fuchigami; Kosei Goto; Maki Hasegawa; Katsuya Saito; Tomoko Kida; Koji Hashimoto; Yukihiko Fujita; Yasuji Inamo; Mitsutaka Kuzuya
Journal:  J Infect Chemother       Date:  2012-05-09       Impact factor: 2.211

10.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion associated with febrile urinary tract infection.

Authors:  Takayuki Okamoto; Yasuyuki Sato; Takeshi Yamazaki; Asako Hayashi
Journal:  Eur J Pediatr       Date:  2013-11-13       Impact factor: 3.183

View more
  17 in total

Review 1.  Reversible splenial lesions presenting in conjunction with febrile illness: a case series and literature review.

Authors:  David Lin; Matthew Rheinboldt
Journal:  Emerg Radiol       Date:  2017-05-18

Review 2.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

3.  Cytotoxic lesions of the corpus callosum after COVID-19 vaccination.

Authors:  Hiroya Ohara; Hironori Shimizu; Takehito Kasamatsu; Akihiro Kajita; Kenji Uno; Khin Wee Lai; Balachandar Vellingiri; Kazuma Sugie; Masako Kinoshita
Journal:  Neuroradiology       Date:  2022-07-09       Impact factor: 2.995

4.  Shigella-associated mild encephalitis with reversible splenial lesion in Hospital Center Delafontaine, Saint-Denis, France: a case report.

Authors:  Louise Le Soudéer; Jeanne Truong; Julie Le Gal; Simon Escoda
Journal:  BMC Pediatr       Date:  2022-07-15       Impact factor: 2.567

5.  Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report.

Authors:  Kundian Guo; Xiaohui Lai; Yue Liu; Dong Zhou; Zhen Hong
Journal:  Neurol Sci       Date:  2021-06-05       Impact factor: 3.307

6.  Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion in an Adult Patient with Influenza.

Authors:  Hana Takatsu; Naoto Ishimaru; Madoka Ito; Saori Kinami
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

7.  Mild encephalopathy with a reversible splenial lesion mimicking transient ischemic attack: A case report.

Authors:  Kai Dong; Qian Zhang; Jianping Ding; Liankun Ren; Zhen Zhang; Longfei Wu; Wuwei Feng; Haiqing Song
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

8.  Reversible splenial lesion syndrome associated with dengue fever: a case report.

Authors:  Pavithra Sathananthasarma; Praveen Nilendra Weeratunga; Thashi Chang
Journal:  BMC Res Notes       Date:  2018-06-27

9.  Reversible splenial lesion syndrome: A differential diagnosis of corpus callosum lesions.

Authors:  Cynthia García Fernández; Pablo A López; Alejandro Caride; Edgar Carnero Contentti
Journal:  Neurol Psychiatry Brain Res       Date:  2018-08-02

10.  Reversible splenial lesion syndrome in children: clinical analysis and summary of a case series.

Authors:  Xinying Zhang; Na Chen; Jiamin Guo; Shuwei Li; Jiaming Xu; Weiwei Zhu; Aihua Ma
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.